OPKO HEALTH, INC. (OPK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 700M 1.4B 2.1B FY09: 4.4M FY10: 28.5M FY11: 28M FY12: 47M FY13: 96.5M FY14: 91.1M FY15: 305.3M FY16: 1.1B FY17: 966M FY18: 990.3M FY19: 901.9M FY20: 1.4B FY21: 1.8B FY22: 1B FY23: 863.5M FY24: 713.1M FY25: 606.9M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 150M 300M 450M FY09: 1.5M FY10: 15M FY11: 10.7M FY12: 19.2M FY22: 288.2M FY23: 318.1M FY24: 218.5M FY25: 205.9M FY09 FY10 FY11 FY12 FY22 FY23 FY24 FY25

Operating Income Annual

-300M -200M -100M 0 100M 200M 300M FY09: -22.1M FY10: -11.1M FY11: -23.2M FY12: -37.3M FY13: -79.6M FY14: -145.8M FY15: -98.5M FY16: -96.6M FY17: -276.4M FY18: -171.2M FY19: -274.1M FY20: 57.7M FY21: 18.8M FY22: -226.3M FY23: -157M FY24: -152.1M FY25: -117.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-450M -300M -150M 0 150M 300M 450M FY09: -30.1M FY10: -18.9M FY11: -1.3M FY12: -29M FY13: -114.4M FY14: -171.7M FY15: -30M FY16: -48.4M FY17: -305.2M FY18: -153M FY19: -314.9M FY20: 30.6M FY21: -30.1M FY22: -328.4M FY23: -188.9M FY24: -53.2M FY25: -225.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 250M 500M 750M FY09: 2.9M FY10: 13.5M FY11: 17.2M FY12: 27.9M FY13: 10.4M FY14: 9.4M FY15: 193.3M FY16: 564.1M FY22: 716M FY23: 545.4M FY24: 494.6M FY25: 400.9M FY10 FY12 FY14 FY16 FY23 FY25

Operating Cash Flow Annual

-210M -140M -70M 0 70M 140M 210M FY09: -23.5M FY10: -18.7M FY11: -18.5M FY12: -25.4M FY13: -55.7M FY14: -90.4M FY15: 164M FY16: 32M FY17: -92.1M FY18: -109.1M FY19: -172.5M FY20: 39.5M FY21: 38.3M FY22: -95.2M FY23: -28.2M FY24: -183.5M FY25: -178.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-240M -160M -80M 0 80M 160M 240M FY09: -23.6M FY10: -19.5M FY11: -20.5M FY12: -26.9M FY13: -59.6M FY14: -95.1M FY15: 153.2M FY16: 13.5M FY17: -138.6M FY18: -137M FY19: -185.3M FY20: 5.8M FY21: 6.2M FY22: -119.8M FY23: -44.5M FY24: -208.5M FY25: -190.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 300M 600M 900M FY09: 233.2M FY10: 255.1M FY11: 280.7M FY15: 488.1M FY16: 555.6M FY17: 559.2M FY18: 563.1M FY19: 595.5M FY20: 640.7M FY21: 648.1M FY22: 719.1M FY23: 751.8M FY24: 694M FY25: 751.1M FY10 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.60 -0.40 -0.20 0.00 0.20 0.40 0.60 Q4 '10: -0.08 Q1 '11: -0.08 Q2 '11: -0.07 Q3 '11: -0.07 Q2 '12: -0.04 Q3 '12: -0.04 Q4 '12: -0.10 Q1 '13: -0.18 Q2 '13: -0.15 Q3 '13: -0.29 Q4 '13: -0.33 Q1 '14: -0.33 Q2 '14: -0.40 Q3 '14: -0.34 Q4 '14: -0.42 Q1 '15: -0.57 Q2 '15: -0.58 Q3 '15: -0.29 Q4 '15: -0.17 Q1 '16: 0.06 Q2 '16: 0.17 Q3 '16: -0.04 Q4 '16: -0.09 Q1 '17: -0.12 Q2 '17: -0.18 Q3 '17: -0.21 Q4 '17: -0.55 Q1 '18: -0.57 Q2 '18: -0.54 Q3 '18: -0.53 Q4 '18: -0.27 Q1 '19: -0.33 Q2 '19: -0.42 Q3 '19: -0.48 Q4 '19: -0.53 Q1 '20: -0.48 Q2 '20: -0.33 Q3 '20: -0.18 Q4 '20: 0.05 Q1 '21: 0.19 Q2 '21: 0.11 Q3 '21: 0.11 Q4 '21: -0.05 Q1 '22: -0.18 Q2 '22: -0.29 Q3 '22: -0.44 Q4 '22: -0.44 Q1 '23: -0.38 Q2 '23: -0.27 Q3 '23: -0.27 Q4 '23: -0.25 Q1 '24: -0.35 Q2 '24: -0.33 Q3 '24: -0.19 Q4 '24: -0.09 Q1 '25: -0.07 Q2 '25: -0.25 Q3 '25: -0.25 Q4 '25: -0.30 Q1 '26: -0.27 Q2 '26: -0.09 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.